TY - JOUR
T1 - Vagal afferents gate cortical excitability in a kainate-induced mouse model of temporal lobe epilepsy
AU - Sayanagi, Taichi
AU - Kosugi, Kenzo
AU - Ascencao, Luisa Cassini
AU - Makino, Kaito
AU - Takabatake, Yuya
AU - Merante, Mariateresa
AU - Suzuki, Takahiro
AU - Abe, Yoshifumi
AU - Teratani, Toshiaki
AU - Toda, Masahiro
AU - Tanaka, Kenji F.
N1 - Publisher Copyright:
© 2026 The Authors
PY - 2026/7/1
Y1 - 2026/7/1
N2 - Background: Vagus nerve stimulation (VNS) is an established therapy for refractory epilepsy, indicating that enhanced vagal activity can suppress excessive brain excitability. However, whether endogenous vagal tone itself serves as an intrinsic antiepileptic mechanism remains unclear. We aimed to determine if endogenous vagal activity restrains epileptic dynamics and to elucidate the neural pathways involved. Methods: We employed an intrahippocampal kainate-induced mouse model of temporal lobe epilepsy and an optogenetic model of hippocampal excitability. We performed gain-of-function studies using cervical VNS (30 Hz) and loss-of-function studies using bilateral subdiaphragmatic vagotomy and selective ablation of VGluT2-positive vagal afferents. Results: Cervical VNS attenuated network hyperexcitability, significantly reducing delta power and root mean square (RMS) amplitude, consistent with its clinical efficacy. By contrast, bilateral subdiaphragmatic vagotomy increased delta power, RMS amplitude, and mortality, demonstrating that endogenous vagal activity restrains epileptic dynamics. In the optogenetic model, VNS suppressed, whereas vagotomy exacerbated, light-evoked after-discharges. Crucially, selective ablation of VGluT2-positive vagal afferents largely abolished the electrophysiological signatures of VNS, including power suppression and network desynchronization, establishing that the antiseizure action of VNS depends on intact afferent pathways. Conclusions: These findings identify endogenous vagal afferent signaling as a tonic brake on epileptic network activity and provide mechanistic evidence that cervical VNS suppresses seizures by amplifying this endogenous pathway. This work presents a conceptual and mechanistic framework for afferent-targeted neuromodulation strategies aimed at improving therapeutic precision in epilepsy.
AB - Background: Vagus nerve stimulation (VNS) is an established therapy for refractory epilepsy, indicating that enhanced vagal activity can suppress excessive brain excitability. However, whether endogenous vagal tone itself serves as an intrinsic antiepileptic mechanism remains unclear. We aimed to determine if endogenous vagal activity restrains epileptic dynamics and to elucidate the neural pathways involved. Methods: We employed an intrahippocampal kainate-induced mouse model of temporal lobe epilepsy and an optogenetic model of hippocampal excitability. We performed gain-of-function studies using cervical VNS (30 Hz) and loss-of-function studies using bilateral subdiaphragmatic vagotomy and selective ablation of VGluT2-positive vagal afferents. Results: Cervical VNS attenuated network hyperexcitability, significantly reducing delta power and root mean square (RMS) amplitude, consistent with its clinical efficacy. By contrast, bilateral subdiaphragmatic vagotomy increased delta power, RMS amplitude, and mortality, demonstrating that endogenous vagal activity restrains epileptic dynamics. In the optogenetic model, VNS suppressed, whereas vagotomy exacerbated, light-evoked after-discharges. Crucially, selective ablation of VGluT2-positive vagal afferents largely abolished the electrophysiological signatures of VNS, including power suppression and network desynchronization, establishing that the antiseizure action of VNS depends on intact afferent pathways. Conclusions: These findings identify endogenous vagal afferent signaling as a tonic brake on epileptic network activity and provide mechanistic evidence that cervical VNS suppresses seizures by amplifying this endogenous pathway. This work presents a conceptual and mechanistic framework for afferent-targeted neuromodulation strategies aimed at improving therapeutic precision in epilepsy.
KW - Network desynchronization
KW - Optogenetics
KW - Temporal lobe epilepsy
KW - Vagal afferents
KW - Vagus nerve stimulation
UR - https://www.scopus.com/pages/publications/105039954690
UR - https://www.scopus.com/pages/publications/105039954690#tab=citedBy
U2 - 10.1016/j.brs.2026.103133
DO - 10.1016/j.brs.2026.103133
M3 - Article
C2 - 42190876
AN - SCOPUS:105039954690
SN - 1935-861X
VL - 19
JO - Brain Stimulation
JF - Brain Stimulation
IS - 4
M1 - 103133
ER -